Our Strategy

Our objective is to develop, in a cost-efficient manner, LCM products, formulations and complex APIs for which we believe there are high barriers to entry and have high value for customers due to the complexity of the manufacturing process and the difficulty in obtaining sufficiently pure pharmaceutical ingredients.

We intend to:

  • Complete clinical development and obtain regulatory approval for our LCM products
  • Develop and commercialize our generic complex API and FDF portfolio
  • Pursue co-development and marketing partnerships
  • Leverage our in-house API and FDF manufacturing capabilities, with significant tax benefits